drug-eluting stent
Optimal duration of dual antiplatelet therapy after drug eluting stent implantation: a network meta-analysis
... after drug eluting stent (DES) implantation has remained in conten- tion, with the recently updated guidelines from major American cardiology societies recommending a minimum of 6 months of aspirin ...
11
Comparison of Full Lesion Coverage versus Spot Drug Eluting Stent Implantation for Coronary Artery Stenoses
... Fig. 2. Subgroup analyses of the 1-year rates of target vessel failure. Subgroup analyses are shown for the target vessel failure at 1 year among subgroups of patients treated with full DES coverage versus spot DES ...
8
Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug Eluting Stent Implantation
... Between July 2010 and December 2011, we identified 121 eli- gible patients (121 lesions) who underwent both pre-proce- dural VH-IVUS examination on de novo lesions and follow-up OCT after DES implantation from an OCT ...
7
Comparison of a drug eluting balloon first and then bare metal stent with a drug eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial
... of drug-eluting stents (DES) has reduced the occurrence of restenosis and sub- sequent need for repeat revascularization [3], the inci- dence of stent thrombosis with DES appeared to be high due to ...
9
Original Article Clinical outcome in patients with stent thrombosis at different times after drug eluting stent implantation
... additional stent implan- tation ...additional stent implantation was signifi- cantly lower in the early group than in the late ...Additional stent implanta- tion is not recommended for patients with ...
10
Coronary Artery Aneurysm after Second Generation Drug Eluting Stent Implantation
... A major adverse cardiac event (MACE) was defined as a com- posite of cardiac death, myocardial infarction, and stent thrombo- sis. All deaths were considered cardiac deaths unless a definite noncardiac cause could ...
8
Impact of Statin Treatment on Strut Coverage after Drug Eluting Stent Implantation
... for this finding is that the vascular healing response to statins or lower LDL cholesterol levels could be different ac- cording to the type of DES. Compared to SESs, BESs have several different characteristics, ...
8
Giant Coronary Artery Pseudoaneurysm after Drug Eluting Stent Implantation
... The patient remained asymptomatic at subsequent follow-ups at our outpatient clinic. Nevertheless, he started to complain of angina after one and half month of DES implantation. Repeat coronary angiography displayed ...
7
A Comparison of Peri Procedural Myocardial Infarction between Paclitaxel Coated Balloon and Drug Eluting Stent on De Novo Coronary Lesions
... ment is an attractive therapeutic option and may have bene- fits over DES. In the absence of stent struts, PCB has consider- ably less chance of side-branch occlusion in theory, compared to stents. However, the ...
6
Prospective and Systematic Analysis of Unexpected Requests for Non Cardiac Surgery or Other Invasive Procedures during the First Year after Drug Eluting Stent Implantation
... after drug-eluting stents (DESs) ...zotarolimus-eluting stent implantation with 3-month DAPT ...or stent thrombosis related with ac- tual discontinuation of ...or stent ...
8
Pharmacoeconomical comparison of bare metal stent and drug eluting stent
... It was a retrospective observational study including 20 patients had undergone surgery of Percutaneous Coronary Intervention (PCI) during December 2007 to June 2009 were being taken as a study population. These patients ...
9
Randomized Comparison of Strut Coverage between Ticagrelor and Clopidogrel in Acute Myocardial Infarction at 3 Month Optical Coherence Tomography
... of stent apposition on post-procedural OCT, suggesting that stent optimisation by improving apposition considering vessel size is more important for improving early strut ...optimal stent size in ...
9
Development of a bioactive polymeric drug eluting coronary stent coating using electrospraying
... of stent surface modification strategies have been investigated in order to provide coatings that accelerate re-endothelialisation of the ...Combo stent TM has anti- CD34 antibodies immobilised on its ...
11
Single centre all comers registry reveals promising long term clinical results of the EndeavorTM Stent
... practice. Material and Methods: Data come from a prospective single-centre registry. Between 2005 and 2007 all patients, who received at least one Endeavor™ coronary stent, were included into a registry. Patients ...
8
Effectiveness and Safety of Biolimus A9™ Eluting stEnt in Patients with AcUTe Coronary sYndrome; A Multicenter, Observational Study (BEAUTY Study)
... The primary efficacy and safety end point was the incidence of major adverse cardiac events (MACE), defined as a composite of cardiac death, non-fatal MI, and clinically-driven target vessel revascularization (TVR), at ...
8
Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus Eluting Stent versus Paclitaxel Eluting Stent
... SE was defined as minimum stent diameter divided by maximum stent diameter. We investigated three different SE parameters defined as follows: 1) SE determined at the lesion site with maximal %NIH area on ...
9
Efficacies of the new Paclitaxel eluting Coroflex Please™ Stent in percutaneous coronary intervention; comparison of efficacy between Coroflex Please™ and Taxus™ (ECO PLEASANT) trial: study rationale and design
... Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions: A randomized comparison of a sirolimus eluting stent with a standard stent for coronary ...
9
Serial Morphological Changes of Side Branch Ostium after Paclitaxel Coated Balloon Treatment of De Novo Coronary Lesions of Main Vessels
... Fig. 1. Pre-procedure (A), post-procedure (B) and follow-up angiographic images (C) coupled to corresponding OCT images. OCT images were captured in corresponding segments through main vessel (D and G) and SB (E, F, H, ...
8
Release mechanism and parameter estimation in drug-eluting stent systems : analytical solutions of drug release and tissue transport
... modelling drug release from arterial stents was presented at the fourth UK Math- ematics in Medicine Study Group (see Green et ...the drug release ...experiments, stent manu- facturers routinely test ...
24
INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug eluting balloon and bare metal stent (IN PACT CORO): study protocol for a randomized controlled trial
... Accordingly, drug-eluting balloons (DEBs) are a promising tool to prevent restenosis and avoid the undesirable persistence of DES polymers in the vessel wall, thus potentially increasing the safety of ...
8